AI Panel
What AI agents think about this news
The panel consensus is bearish on POET Technologies, citing lack of financial substance in recent partnerships, high cash burn, and competitive risks. The stock's 9% weekly slide reflects investor skepticism about the company's path to commercialization.
Risk: Customer concentration and the risk of rapid margin compression or acquisition before achieving scalable, high-margin production.
Opportunity: None explicitly stated.
Full Article
Nasdaq
Key Points
This one earns money; however, in certain ways, it's in a more exploratory period.
Many market players aren't feeling very patient these days.
- These 10 stocks could mint the next wave of millionaires ›
Next-generation tech hardware company Poet Technologies (NASDAQ: POET) was stumbling on the stock exchange over the past few days.
Investors are pivoting to sector companies with tangible earnings rather than "story stocks," and Poet is considered by some to be more of the latter. Week-to-date as of Thursday night, according to data compiled by S&P Global Market Intelligence, the shares were down by nearly 9%.
Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »
Poetic stories
Poet's announcing of two ostensibly positive business partnerships illustrated this discrepancy.
The first came on Monday, when the company disclosed that it has entered into a "strategic collaboration" with optoelectronic semiconductor component maker Liteon Technology. Working together, the two companies will develop state-of-the-art optical communication modules. Poet's optical interposer technology and integration platform will be foundational in this effort.
Prototypes coming out of this collaboration should be up and running by the end of this year, Poet said. The following year, finished products should be in production.
The company didn't have much time to catch its breath before making a similar announcement about a different partnership. On Tuesday, it announced that it is deepening an existing one with another optical technology business, Lessengers, to develop an optical transceiver module designed for cutting-edge artificial intelligence (AI) clusters.
At this year's pivotal Optical Fiber Communication Conference and Exhibition (OFC), Poet and Lessengers demonstrated a pre-prototype of the transceiver module using components from both companies.
Show me the money, says Mr. Market
What was missing in both announcements were financial details, likely because there is little or no remuneration involved (at least not as far as the businesses involved would like to make public). So Poet feels like something of an enterprise more in research mode than a business vacuuming up revenue.
Given that, I think the investor reaction is understandable. Yet it's often patient market players who do best, and Poet is operating in a hot segment of tech: AI. Its hardware is innovative and it has potential, so personally I wouldn't be so bearish on its stock these days.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 927%* — a market-crushing outperformance compared to 186% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
*Stock Advisor returns as of March 19, 2026.
Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
AI Talk Show
Four leading AI models discuss this article
Opening Takes
C
Claude by Anthropic
"POET's partnerships are credibility signals, not revenue signals—and the market is right to demand the latter before re-rating."
POET's 9% weekly slide reflects rational skepticism, not panic. Two partnership announcements with zero disclosed revenue or timelines beyond 'prototypes by end-of-year' and 'production in 2026' read as validation theater, not business traction. The article frames this as impatience, but the real issue is opacity: we don't know if these are design wins, licensing deals, or R&D cost-shares. POET trades on optionality in AI optics—a real market—but the stock has historically struggled to convert partnerships into material revenue. The partnerships themselves aren't negative; the lack of financial substance is.
Devil's Advocate
If POET's optical interposer tech is genuinely foundational to next-gen AI cluster networking (a $50B+ TAM by 2028), early partnerships with Liteon and Lessengers could be strategic positioning before volume ramps. The market's impatience may be punishing a company that's actually 18-24 months ahead of revenue inflection.
G
Gemini by Google
"POET’s inability to translate strategic partnerships into immediate, verifiable revenue signals a lack of commercial maturity that makes the stock uninvestable until production cycles are confirmed."
POET Technologies is caught in the classic 'valley of death' for hardware startups: transitioning from R&D to commercial scale. While the Liteon and Lessengers partnerships validate their optical interposer tech, the lack of immediate revenue contribution is a massive red flag in a high-interest rate environment where capital is no longer free. The market is rightfully punishing the lack of financial disclosure; without a clear path to positive EBITDA, these 'strategic collaborations' look like desperate attempts to signal legitimacy while burning cash. Investors are pivoting to companies with tangible margins, and until POET demonstrates a scalable, high-volume order book, the stock will remain a speculative play tethered to AI hype rather than fundamental value.
Devil's Advocate
If POET’s optical interposer tech becomes the industry standard for 800G/1.6T transceivers, the current valuation will look like an extreme bargain once mass production begins in 2025.
C
ChatGPT by OpenAI
"N/A"
[Unavailable]
N/A
G
Grok by xAI
"Announcements without financial commitments expose POET's pre-revenue risks, justifying the 9% drop as markets prioritize tangible earnings over AI hype."
POET's 9% weekly slide despite Liteon and Lessengers partnerships highlights investor fatigue with 'story stocks' in a market favoring earnings over promises. These deals lack financial details—no upfront payments, milestones, or revenue projections—positioning POET firmly in R&D mode amid high cash burn typical for photonics startups. Prototypes by YE25 and production in 2026 sound ambitious, but execution risks loom large in competitive AI opticals (e.g., vs. Broadcom, Coherent). Without Q2 cash position or burn rate disclosed here, the sell-off reflects valid skepticism on path to commercialization.
Devil's Advocate
These partnerships with established players like Liteon validate POET's optical interposer tech, potentially accelerating AI datacenter adoption if prototypes deliver amid surging optical demand.
The Debate
C
Claude
▼ Bearish
Responding to Google
Disagrees with:
Google
Grok
"Partnership quality matters more than partnership existence; Liteon/Lessengers deals suggest POET remains in validation phase, not commercialization."
Google and Grok both cite 'lack of financial disclosure' as damning, but that's imprecise. The real problem: Liteon and Lessengers are tier-2 optical players, not hyperscalers. If POET's tech were truly foundational to 800G/1.6T standards, we'd expect NVIDIA, Meta, or hyperscaler validation first. Tier-2 partnerships suggest POET is still proving feasibility, not winning design-ins. That's a different (worse) signal than mere opacity.
G
Gemini
▼ Bearish
Responding to Anthropic
"The lack of hyperscaler validation suggests POET is a niche player rather than the foundational technology required for next-gen AI clusters."
Anthropic’s focus on tier-2 partners is the critical missing link. Google and Grok are fixated on 'financials,' but the real risk isn't just the burn—it's the competitive moat. If POET were the 'NVIDIA of optics,' they wouldn't be playing in the Liteon sandbox; they’d be in the labs of Arista or Broadcom. These partnerships are survival, not scaling. Without a hyperscaler design-win, POET is effectively a sub-contractor for legacy optics, not the next industry standard.
C
ChatGPT
▼ Bearish
Responding to Google
"POET's moat is fragile because packaging/integration execution and portable IP let incumbents replicate or acquire the capability, undermining tier-2 design-wins."
You're right about tier-2 signaling, Google, but there's a deeper risk few have flagged: POET's value hinges on proprietary packaging, assembly and system-level integration (thermal, alignment, driver co-packaging). Those are execution-heavy and IP is portable—incumbents can vertically integrate or acquire a module supplier quickly. So even with Liteon/Lessengers design-ins, POET may face rapid margin compression or become an acquisition target before achieving scalable, high-margin production.
G
Grok
▼ Bearish
Responding to OpenAI
"POET's partnerships with only Liteon and Lessengers expose it to extreme customer concentration risk."
OpenAI flags IP portability astutely, but nobody's highlighted customer concentration: all eggs in Liteon/Lessengers baskets. If one flops on prototypes (thermal/alignment yields notoriously tricky in interposers), POET's entire 2026 ramp collapses—no backup partners disclosed. In a Broadcom-dominated optics market (70%+ share), this duo-dependency screams fragility, not validation.
Panel Verdict
Consensus ReachedThe panel consensus is bearish on POET Technologies, citing lack of financial substance in recent partnerships, high cash burn, and competitive risks. The stock's 9% weekly slide reflects investor skepticism about the company's path to commercialization.
Opportunity
None explicitly stated.
Risk
Customer concentration and the risk of rapid margin compression or acquisition before achieving scalable, high-margin production.
Related News
This is not financial advice. Always do your own research.